Progress of molecular markers in adult acute B-lymphoblastic leukemia
10.3760/cma.j.cn115356-20211219-00299
- VernacularTitle:成年人急性B淋巴细胞白血病分子标志物的研究进展
- Author:
Jiaqi WANG
1
;
Quanyi LU
Author Information
1. 厦门大学医学院研究生院，厦门 361102
- Keywords:
Precursor cell lymphoblastic leukemia-lymphoma;
Tumor markers, biological;
Diagnosis;
Prognosis
- From:
Journal of Leukemia & Lymphoma
2022;31(8):509-512
- CountryChina
- Language:Chinese
-
Abstract:
Acute lymphoblastic leukemia (ALL) is a malignant tumor dominated by B-cell or T-cell proliferation, of which 80% is the malignant proliferation of B-lymphocytes, and it can be more commonly seen in children. Studies have found that ALL is often accompanied by abnormal molecular biological phenotypes. The study of the molecular biological characteristics of ALL helps the precise diagnosis, prognostic analysis, pathogenesis research and the discovery of new diagnostic markers and therapeutic targets. This article summarizes several molecular markers of adult acute B-lymphoblastic leukemia discovered in recent years, and reviews the clinical significance.
